Three Generations, 78 Years of Data, 15,000 Participants, 2 Million Biosamples, and More to Discover
This Framingham Heart Study Summit on Recent Scientific Findings event will highlight the enduring impact of the Framingham Heart Study, the landmark longitudinal study that has reshaped our understanding of cardiovascular disease and continues to drive discoveries across a wide range of health conditions. This gathering will explore how decades of rigorous population-based research have led not only to breakthroughs in heart disease and stroke, but also to transformative insights into conditions such as cognitive decline, dementia, osteoporosis, arthritis, obesity, cancer, kidney and lung health, and even eye and hearing disorders.
Attendees will learn how the Framingham Heart Study evolved from a pioneering effort to uncover the causes of cardiovascular disease into a network of studies involving more than 15,000 participants, and how its collaborative model continues to fuel discovery. Join us to explore new opportunities for interdisciplinary partnership and to learn more about the scientific advances made possible through this long-standing research enterprise. View agenda (download) and slides (download).
Featuring
Host
” alt=”Donald Lloyd-Jones” width=”100″ height=”150″>Donald Lloyd-Jones
Framingham Center for Population and Prevention Science, Framingham Heart Study Principal Investigator, Framingham Heart Study Professor, Medicine Section Chief, Preventive Medicine and Epidemiology
-
Panelists
” alt=”Lindsay Farrer” width=”100″ height=”150″>Lindsay Farrer
Professor anatomy and Neurobiology Professor of medicine, neurology, Ophthalmology, Genetics, Genomics, Epidemiology, and Biostatistics
Chief of Biomedical Statistics
” alt=”Jessica Fetterman” width=”100″ height=”150″>
” alt=”Douglas Kiel” width=”100″ height=”150″>
” alt=”Daniel Levy” width=”100″ height=”150″>
” alt=”Jesse Mez” width=”100″ height=”150″>
” alt=”Gary Mitchell” width=”100″ height=”150″>
” alt=”Joanne Murabito” width=”100″ height=”150″>
” alt=”Matthew Naylor” width=”100″ height=”150″>
” alt=”George O’Connor” width=”100″ height=”150″>
” alt=”Nicole Spartano” width=”100″ height=”150″>
” alt=”Alexander V. Stanisic” width=”100″ height=”150″>
” alt=”Vanessa Xanthakis” width=”100″ height=”150″>
” alt=”Andrew Johnson” width=”100″ height=”150″>Investigator and Head, Biomedical Informatics
National Heart, Lung, and Blood Institute
Cardiovascular Epidemiology and Human Genomics Branch
” alt=”Maura Walker” width=”100″ height=”150″>
” alt=”Chunyu Liu” width=”100″ height=”150″>
” alt=”Yorghos Tripodis” width=”100″ height=”150″>
” alt=”Hugo J. Aparicio” width=”100″ height=”150″>
” alt=”Jose Rafael Romero” width=”100″ height=”150″>
” alt=”Framingham Heart Study” width=”100″ height=”150″>About Research on Tap
The Research on Tap series, sponsored by the BU Office of Research, brings together groups of BU researchers around important topics. At each event, 10-12 researchers present a maximum of four slides and deliver a four-minute “elevator pitch” of their work. Research on Tap events are open to faculty, staff, postdocs, and graduate students. Each presentation is followed by refreshments and lively discussion with colleagues and potential collaborators.
Learn More About The Framingham Heart Study
” alt=”Rhoda Au” width=”100″ height=”150″>